Updated:
Daocin Capital
Daocin Capital manages private equity investments focused on early-stage opportunities from Hangzhou.
Daocin Capital
Daocin Capital is an angel investor focused on investments in artificial intelligence, Fin-tech, sharing economy, and robotics. They have made 73 investments. Their most recent investment was in Boonray as part of their Series B - II on June 19, 2025.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Hangzhou
Corporate office
Hangzhou, China
Sector focus
Frequently asked questions
Who runs investment decisions at Daocin Capital?
No named principals or investment committee members are disclosed in available records.
Does Daocin Capital participate in fund commitments or only direct deals?
Available information indicates a focus on direct early-stage deployments rather than fund commitments.
What investment stages does Daocin Capital typically target?
The firm targets early stage, seed, and start-up opportunities within a venture framework.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: